Motivating sample sizes in adaptive Phase I trials via Bayesian posterior credible intervals

DOI10.1111/BIOM.12872zbMath1414.62434OpenAlexW2792307526WikidataQ88041215 ScholiaQ88041215MaRDI QIDQ4628378

Thomas M. Braun

Publication date: 13 March 2019

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://hdl.handle.net/2027.42/146418

zbMATH Keywords

maximum tolerated dosedose-findingcontinual reassessment methoddose-limiting toxicitynonparametric optimal design

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Nonparametric tolerance and confidence regions (62G15)

This page was built for publication: Motivating sample sizes in adaptive Phase I trials via Bayesian posterior credible intervals